Basel, Switzerland

Simon Anderhub

This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Phenex Discovery Verwaltungs-Gmbh. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Simon Anderhub. Retrieved from https://idiyas.com/inventor/simon-anderhub

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 6.0

0

Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Simon Anderhub

Introduction

Simon Anderhub, a notable inventor based in Basel, Switzerland, has made significant strides in the field of pharmaceuticals through his innovative work. His expertise and research have culminated in the development of a patented compound that addresses critical medical needs.

Latest Patents

Simon Anderhub holds a patent for "Substituted N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase." This invention represents a breakthrough in modulating indoleamine 2,3-dioxygenase (IDO1), which is associated with various diseases. The invention specifically offers compounds that can be used in the prophylaxis and treatment of IDO1-mediated diseases, including enantiomers, diastereomers, tautomers, or pharmaceutically acceptable salts thereof.

Career Highlights

Simon currently works at Phenex Discovery Verwaltungs GmbH, where he collaborates with a team of experts dedicated to advancing drug discovery and development. His efforts in research have established him as a prominent figure in the field of medicinal chemistry and pharmaceutical innovations.

Collaborations

Throughout his career, Simon has had the opportunity to work alongside esteemed colleagues such as Christoph Steeneck and Olaf Kinzel. Their collaborative efforts have further propelled the advancements in their respective research areas, fostering an innovative environment focused on discovering potent therapeutic agents.

Conclusion

With his patent and ongoing work at Phenex Discovery Verwaltungs GmbH, Simon Anderhub exemplifies the essence of innovation in pharmaceuticals. His contributions to the modulation of IDO1 through his invention are noteworthy and illustrate the impact inventors can have on medical science and treatment options. Simon's journey is a testament to the importance of creativity and research in addressing global health challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…